Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Sheiner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Statistics in Medicine|April 15, 2006
Diagnostics for confounding in PK/PD models for oxcarbazepineJerry R Nedelman, Donald B Rubin, Lewis B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2007
Population pharmacokinetics of nicotine and its metabolites I. Model developmentMicha Levi, Delia A Dempsey, Neal L Benowitz, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2007
Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model applicationMicha Levi, Delia A Dempsey, Neal L Benowitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administrationJian-Feng Lu, Terrence F Blaschke, Charles Flexner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2006
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteriaSmita A Kshirsagar, Terrence F Blaschke, Lewis B Sheiner, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398Marc Pfister, Line Labbé, Scott M Hammer, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacinMarc Pfister, Liping Zhang, Margareta Hammarlund-Udenaes, et al.
Clinical Pharmacology and Therapeutics|December 10, 2003
Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationshipsDolors Soy, Francesca T Aweeka, Joseph A Church, et al.
Clinical Pharmacology and Therapeutics|May 7, 2003
Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitorsCarla B Washington, Charles Flexner, Lewis B Sheiner, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirMarc Pfister, Line Labbé, Jian-Feng Lu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Statistics in Medicine|April 15, 2006
Diagnostics for confounding in PK/PD models for oxcarbazepineJerry R Nedelman, Donald B Rubin, Lewis B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2007
Population pharmacokinetics of nicotine and its metabolites I. Model developmentMicha Levi, Delia A Dempsey, Neal L Benowitz, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2007
Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model applicationMicha Levi, Delia A Dempsey, Neal L Benowitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administrationJian-Feng Lu, Terrence F Blaschke, Charles Flexner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2006
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteriaSmita A Kshirsagar, Terrence F Blaschke, Lewis B Sheiner, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398Marc Pfister, Line Labbé, Scott M Hammer, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacinMarc Pfister, Liping Zhang, Margareta Hammarlund-Udenaes, et al.
Clinical Pharmacology and Therapeutics|December 10, 2003
Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationshipsDolors Soy, Francesca T Aweeka, Joseph A Church, et al.
Clinical Pharmacology and Therapeutics|May 7, 2003
Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitorsCarla B Washington, Charles Flexner, Lewis B Sheiner, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirMarc Pfister, Line Labbé, Jian-Feng Lu, et al.
Pageof 2